Compounded tirzepatide
Sold by Dr.Arevitalize · Oral tablet · every compounded tirzepatide record
What you actually pay
Per month
$349
| Medication · 1-month price, oral capsules | $349 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| 1-month price, oral capsules “Tirzepatide Oral Capsules $349.00” | Per month$349 | Charged today$349 |
We earn nothing from this link. Dr.Arevitalize has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | “No, there are no long-term commitments. Our flexible plans and transparent pricing let you choose the care that's right for you, with full control at every step.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from drarevitalize.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The fetcher's SPA excuse was correct about the mechanism (the page really is client-rendered and shows a bare 'LOADING' placeholder before hydration) but wrong about the conclusion — after the render wait, the full storefront, FAQ and all four GLP-1 products with prices are visible. Both an injectable and an oral capsule product line exist for the same drug names; the 4th product ('Semaglutide vs Tirzepatide' — actually 'Tirzepatide Oral Capsules') is recorded under drug=compounded tirzepatide since the page never calls it a brand. Deep links (/pricing, /weight-loss, /glp-1, /legal/terms-of-service) all 404 on direct navigation — this is a client-side-routed app whose sub-routes only resolve when reached by an in-page click, so terms/cancellation detail beyond the homepage FAQ could not be confirmed.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.